1132817-33-4

Basic information

• Product Name: 2-{3-[4-(4-methyl-1H-imidazol-1-yl)phenyl]-2-oxo-1,4-diazaspiro[4.4]non-3-en-1-yl}-N-[3-(trifluoromethyl)phenyl]acetamide
• Synonyms: 2-{3-[4-(4-methyl-1H-imidazol-1-yl)phenyl]-2-oxo-1,4-diazaspiro[4.4]non-3-en-1-yl}-N-[3-(trifluoromethyl)phenyl]acetamide
• CAS NO: 1132817-33-4
• Molecular Weight: 495.504
• Mol File: 1132817-33-4.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2-{3-[4-(4-methyl-1H-imidazol-1-yl)phenyl]-2-oxo-1,4-diazaspiro[4.4]non-3-en-1-yl}-N-[3-(trifluoromethyl)phenyl]acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-{3-[4-(4-methyl-1H-imidazol-1-yl)phenyl]-2-oxo-1,4-diazaspiro[4.4]non-3-en-1-yl}-N-[3-(trifluoromethyl)phenyl]acetamide(1132817-33-4)
• EPA Substance Registry System: 2-{3-[4-(4-methyl-1H-imidazol-1-yl)phenyl]-2-oxo-1,4-diazaspiro[4.4]non-3-en-1-yl}-N-[3-(trifluoromethyl)phenyl]acetamide(1132817-33-4)

Safety Data

• Hazardous Substances Data: 1132817-33-4(Hazardous Substances Data)

Upstream product

• 1369762-45-7 benzyl 2-oxo-2-(2-oxo-2-(3-(trifluoromethyl)phenylamino)ethylamino)ethylcarbamate 
• 1183381-25-0 2-amino-N-(2-oxo-2-(3-(trifluoromethyl)phenylamino)ethyl)acetamide 
• 1369762-46-8 2-(2-oxo-1,4-diazaspiro[4.4]nonan-1-yl)-N-(3-(trifluoromethyl)phenyl)acetamide 
• 1369762-47-9 3-oxo-4-(2-oxo-2-(3-(trifluoromethyl)phenylamino)ethyl)-1,4-diazaspiro[4.4]non-1-ene 1-oxide 
• 1369762-48-0 2-(4-(4-methyl-1H-imidazol-1-yl)phenyl)-3-oxo-4-(2-oxo-2-(3-(trifluoromethyl)phenylamino)ethyl)-1,4-diazaspiro[4.4]non-1-ene 1-oxide 
• 98-16-8 3-trifluoromethylaniline 
• 41841-16-1 (4-bromo-phenyl)-acetic acid methyl ester 
• 1132817-67-4 3-[4-(4-methyl-1H-imidazol-1-yl)phenyl]-1,4-diazaspiro[4.4]non-3-en-2-one 
• 351-38-2 N-chloroacetyl-3-(trifluoromethyl)aniline 
• 1122-91-4 4-bromo-benzaldehyde 
• 104-88-1 4-chlorobenzaldehyde 
• 950589-52-3 3-(4-chlorophenyl)-1,4-diazaspiro[4.4]nonan-2-one 
• 950651-29-3 3-(4-bromophenyl)-1,4-diazaspiro[4.4]nonan-2-one 
• 79-04-9 chloroacetyl chloride 

Downstream Products

• 1132817-31-2 2-{3-[4-(4-methyl-1H-imidazol-1-yl)phenyl]-2-oxo-1,4-diazaspiro[4.4]non-3-en-1-yl}-N-[3-(trifluoromethyl)phenyl]acetamide hydrochloride 

Relevant articles and documents

Novel one-pot synthesis of imidazolinones from esters: A concise synthesis of GSK2137305

A new copper-catalyzed one-pot reaction resulted in the practical synthesis of imidazolinones in moderate yields from esters. The use of inexpensive copper iodide as the catalyst, (NH4)2CO3 as the nitrogen source and readi

Completely N1-selective palladium-catalyzed arylation of unsymmetric imidazoles: Application to the synthesis of nilotinib

The completely N1-selective Pd-catalyzed arylation of unsymmetric imidazoles with aryl halides and triflates is described. This study showed that imidazoles have a strong inhibitory effect on the in situ formation of the catalytically active Pd(0)-ligand complex. The efficacy of the N-arylation reaction was improved drastically by the use of a preactivated solution of Pd2(dba)3 and L1. From these findings, it is clear that while imidazoles can prevent binding of L1 to Pd, once the ligand is bound to the metal, these heterocycles do not displace it. The utility of the present catalytic system was demonstrated by the regioselective synthesis of the clinically important tyrosine kinase inhibitor nilotinib.

SPIRO-CONDENSED IMIDAZOLONE DERIVATIVES INHIBITING THE GLYCINE TRANSPORTER

Compounds of formula (I) and salts thereof are provided: formula (I), wherein the groups are as defined in the specification. Uses of the compounds as medicaments, and in the manufacture of medicament for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder are also disclosed. The invention further comprises processes to make these compounds and pharmaceutical formulations thereof.